Can Fractyl Labs and Cala Health go where only drugs have gone before?
In this week’s episode of the DeviceTalks Weekly podcast, co-hosts Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences, review this week's Top 5 medtech stories, aka “Newmarker’s Newsmakers,” with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer.
We also hear from two executives from Fractyl Laboratories — CEO Dr. Harith Rajagopalan and CFO Lisa Davidson — about its recent $55 million Series E round of financing and the strides they're making in developing a device to treat diabetes.
In a second interview, Cala Health CEO Renee Ryan gives us an update on the Cala Trio’s clinical success and how the start-up is working through COVID-19.
Finally, Chris and Tom hint at an upcoming event for the DTW community.
We also hear from two executives from Fractyl Laboratories — CEO Dr. Harith Rajagopalan and CFO Lisa Davidson — about its recent $55 million Series E round of financing and the strides they're making in developing a device to treat diabetes.
In a second interview, Cala Health CEO Renee Ryan gives us an update on the Cala Trio’s clinical success and how the start-up is working through COVID-19.
Finally, Chris and Tom hint at an upcoming event for the DTW community.
Activity